AG0302-COVID‑19
From Wikipedia, the free encyclopedia
Vaccine candidate against COVID-19
Vaccine description | |
---|---|
Target | SARS-CoV-2 |
Vaccine type | DNA |
Clinical data | |
Routes of administration | Intramuscular, Intradermal[1] |
Part of a series on the |
COVID-19 pandemic |
---|
|
Timeline 2019 2020
2021
2022 |
Locations By country and territory
By conveyance
|
International response
National responses |
Medical response
Vaccines
|
Economic impact and recession
By country
|
Impacts
|
COVID-19 portal |
|
AG0302-COVID‑19 is a COVID-19 vaccine candidate developed by AnGes Inc.[2][3]
This candidate followed a previous one called AG0301-COVID‑19.[4]
References[]
- ^ "Phase I/II Study of COVID-19 DNA Vaccine (AG0302-COVID19 High-dose)". clinicaltrials.gov. United States National Library of Medicine. Retrieved 6 October 2021.
- ^ "Study of COVID-19 DNA Vaccine (AG0302-COVID19)". clinicaltrials.gov. United States National Library of Medicine. 3 December 2020. Retrieved 11 March 2021.
- ^ "Phase II / III Study of COVID-19 DNA Vaccine (AG0302-COVID19)". clinicaltrials.gov. United States National Library of Medicine. Retrieved 11 March 2021.
- ^ "Study of COVID-19 DNA Vaccine (AG0301-COVID19)". ClinicalTrials.gov. United States National Library of Medicine. 9 July 2020. NCT04463472. Archived from the original on 11 October 2020. Retrieved 14 July 2020.
Scholia has a profile for AG0302-COVID‑19 (Q106514993). |
Artificial induction of immunity / Immunization: Vaccines, Vaccination, Infection, Inoculation (J07) | |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Development |
| ||||||||||
Classes |
| ||||||||||
Administration |
| ||||||||||
Vaccines |
| ||||||||||
Inventors/ researchers |
| ||||||||||
Controversy |
| ||||||||||
Related |
| ||||||||||
|
COVID-19 pandemic | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Portals:
Medicine
Viruses
COVID-19
This article about COVID-19 vaccines is a stub. You can help Wikipedia by . |
- v
- t
This article about vaccines or vaccination is a stub. You can help Wikipedia by . |
- v
- t
Retrieved from ""
Categories:
- Clinical trials
- Japanese COVID-19 vaccines
- DNA vaccines
- COVID-19 vaccine stubs
- Vaccine stubs
Hidden categories:
- Articles with short description
- Short description matches Wikidata
- Use dmy dates from April 2021
- Chemical articles without CAS registry number
- Articles without EBI source
- Chemical pages without ChemSpiderID
- Chemical pages without DrugBank identifier
- Articles without KEGG source
- Articles without InChI source
- Articles without UNII source
- Drugs missing an ATC code
- Drugs with no legal status
- Articles containing unverified chemical infoboxes
- Drugs that are a vaccine
- Interlanguage link template forcing interwiki links
- All stub articles